For a study, researchers sought to review the in-patient (IP) treatment styles and 30-day outcomes for patients hospitalized with macroscopic haematuria (MH) throughout the course of a particular institution’s 1-year period to explain future care for similar instances.

All patients with MH admitted to a single facility over the course of a year were the subject of a retrospective cohort research, which excluded patients who did not require an overnight stay. In addition, a case note review was conducted for patient demographics, MH investigations, and care.

Over the course of a year, 120 people with MH in total were hospitalized. The mean length of stay (LOS) was 5 days (1-31 days), the average age of 89% (107/120) of males was 78 years (36-97 years), the average ASA was 3, and 68% of the patients (82/120) had pre-existing urological problems. Bladder irrigation was necessary for 62% of patients (74/120), on average, for 3 days (1-16 days). In order to control the bleeding, 10% (12/120) required an urgent rigid cystoscopy and washout, and 4% (5/12) of these cases revealed malignancy. About 8% (10/120) of released patients experienced unanticipated readmissions within 30 days or more than 8%. The cohort had a 23% (28/120) 1-year death rate, of which 21% (6/28) occurred within 30 days after discharge.

IP MH impacts an exposed patient population. However, the inpatient care of MH does not currently follow a defined pathway. Hence research was needed to develop standardized pathways for managing MH, considering the high 1-year death rate, the high-risk patient demographic, and the longer LOS.